Literature DB >> 34777389

Spatial Profiles of Intratumoral PD-1+ Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma.

Kanako Yoshimura1, Takahiro Tsujikawa1,2, Junichi Mitsuda1, Hiroshi Ogi3,4, Sumiyo Saburi1, Gaku Ohmura1, Akihito Arai1, Saya Shibata4, Guillaume Thibault5, Young Hwan Chang5,6,7, Daniel R Clayburgh7,8, Satoru Yasukawa9,10, Aya Miyagawa-Hayashino9, Eiichi Konishi9, Kyoko Itoh3, Lisa M Coussens2,7, Shigeru Hirano1.   

Abstract

Background: Functional interactions between immune cells and neoplastic cells in the tumor immune microenvironment have been actively pursued for both biomarker discovery for patient stratification, as well as therapeutic anti-cancer targets to improve clinical outcomes. Although accumulating evidence indicates that intratumoral infiltration of immune cells has prognostic significance, limited information is available on the spatial infiltration patterns of immune cells within intratumoral regions. This study aimed to understand the intratumoral heterogeneity and spatial distribution of immune cell infiltrates associated with cell phenotypes and prognosis in head and neck squamous cell carcinoma (HNSCC).
Methods: A total of 88 specimens of oropharyngeal squamous cell carcinoma, categorized into discovery (n = 38) and validation cohorts (n = 51), were analyzed for immune contexture by multiplexed immunohistochemistry (IHC) and image cytometry-based quantification. Tissue segmentation was performed according to a mathematical morphological approach using neoplastic cell IHC images to dissect intratumoral regions into tumor cell nests versus intratumoral stroma.
Results: Tissue segmentation revealed heterogeneity in intratumoral T cells, varying from tumor cell nest-polarized to intratumoral stroma-polarized distributions. Leukocyte composition analysis revealed higher ratios of TH1/TH2 in tumor cell nests with higher percentages of helper T cells, B cells, and CD66b+ granulocytes within intratumoral stroma. A discovery and validation approach revealed a high density of programmed death receptor-1 (PD-1)+ helper T cells in tumor cell nests as a negative prognostic factor for short overall survival. CD163+ tumor-associated macrophages (TAM) provided the strongest correlation with PD-1+ helper T cells, and cases with a high density of PD-1+ helper T cells and CD163+ TAM had a significantly shorter overall survival than other cases.
Conclusion: This study reveals the significance of analyzing intratumoral cell nests and reports that an immune microenvironment with a high density of PD-1+ helper T cells in tumoral cell nests is a poor prognostic factor for HNSCC.
Copyright © 2021 Yoshimura, Tsujikawa, Mitsuda, Ogi, Saburi, Ohmura, Arai, Shibata, Thibault, Chang, Clayburgh, Yasukawa, Miyagawa-Hayashino, Konishi, Itoh, Coussens and Hirano.

Entities:  

Keywords:  Head and neck cancer; PD-1; helper T cell; multiplex immunohistochemistry; tumor heterogeneity

Mesh:

Substances:

Year:  2021        PMID: 34777389      PMCID: PMC8581667          DOI: 10.3389/fimmu.2021.769534

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  48 in total

Review 1.  Th1/Th2 balance in cancer, transplantation and pregnancy.

Authors:  M R Shurin; L Lu; P Kalinski; A M Stewart-Akers; M T Lotze
Journal:  Springer Semin Immunopathol       Date:  1999

2.  The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.

Authors:  Shogo Kumagai; Yosuke Togashi; Takahiro Kamada; Eri Sugiyama; Hitomi Nishinakamura; Yoshiko Takeuchi; Kochin Vitaly; Kota Itahashi; Yuka Maeda; Shigeyuki Matsui; Takuma Shibahara; Yasuho Yamashita; Takuma Irie; Ayaka Tsuge; Shota Fukuoka; Akihito Kawazoe; Hibiki Udagawa; Keisuke Kirita; Keiju Aokage; Genichiro Ishii; Takeshi Kuwata; Kenta Nakama; Masahito Kawazu; Toshihide Ueno; Naoya Yamazaki; Koichi Goto; Masahiro Tsuboi; Hiroyuki Mano; Toshihiko Doi; Kohei Shitara; Hiroyoshi Nishikawa
Journal:  Nat Immunol       Date:  2020-08-31       Impact factor: 25.606

3.  IL-10 in the microenvironment of HNSCC inhibits the CpG ODN induced IFN-α secretion of pDCs.

Authors:  Karl-Ludwig Bruchhage; Sabrina Heinrichs; Barbara Wollenberg; Ralph Pries
Journal:  Oncol Lett       Date:  2018-01-11       Impact factor: 2.967

4.  Non-conventional Inhibitory CD4+Foxp3-PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity.

Authors:  Roberta Zappasodi; Sadna Budhu; Matthew D Hellmann; Michael A Postow; Yasin Senbabaoglu; Sasikanth Manne; Billel Gasmi; Cailian Liu; Hong Zhong; Yanyun Li; Alexander C Huang; Daniel Hirschhorn-Cymerman; Katherine S Panageas; E John Wherry; Taha Merghoub; Jedd D Wolchok
Journal:  Cancer Cell       Date:  2018-06-11       Impact factor: 31.743

5.  Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.

Authors:  Deanne M R Lathers; M Rita I Young
Journal:  Cytokine       Date:  2004-03-07       Impact factor: 3.861

Review 6.  CODEX multiplexed tissue imaging with DNA-conjugated antibodies.

Authors:  Sarah Black; Darci Phillips; John W Hickey; Julia Kennedy-Darling; Vishal G Venkataraaman; Nikolay Samusik; Yury Goltsev; Christian M Schürch; Garry P Nolan
Journal:  Nat Protoc       Date:  2021-07-02       Impact factor: 13.491

7.  FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy.

Authors:  Erin Larkins; Gideon M Blumenthal; Weishi Yuan; Kun He; Rajeshwari Sridhara; Sriram Subramaniam; Hong Zhao; Chao Liu; Jingyu Yu; Kirsten B Goldberg; Amy E McKee; Patricia Keegan; Richard Pazdur
Journal:  Oncologist       Date:  2017-05-22

8.  Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry.

Authors:  Yu-Kuan Huang; Minyu Wang; Yu Sun; Natasha Di Costanzo; Catherine Mitchell; Adrian Achuthan; John A Hamilton; Rita A Busuttil; Alex Boussioutas
Journal:  Nat Commun       Date:  2019-09-02       Impact factor: 14.919

9.  Analysis of Immune Microenvironment by Multiplex Immunohistochemistry Staining in Different Oral Diseases and Oral Squamous Cell Carcinoma.

Authors:  Bin Qiao; Junwen Huang; Zi Mei; Alfred King-Yin Lam; Junfang Zhao; Le Ying
Journal:  Front Oncol       Date:  2020-12-08       Impact factor: 6.244

10.  Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome.

Authors:  Shannon M Liudahl; Courtney B Betts; Shamilene Sivagnanam; Jonathan A Nowak; Brian M Wolpin; Lisa M Coussens; Vicente Morales-Oyarvide; Annacarolina da Silva; Chen Yuan; Samuel Hwang; Alison Grossblatt-Wait; Kenna R Leis; William Larson; Meghan B Lavoie; Padraic Robinson; Andressa Dias Costa; Sara A Väyrynen; Thomas E Clancy; Douglas A Rubinson; Jason Link; Dove Keith; Wesley Horton; Margaret A Tempero; Robert H Vonderheide; Elizabeth M Jaffee; Brett Sheppard; Jeremy Goecks; Rosalie C Sears; Byung S Park; Motomi Mori
Journal:  Cancer Discov       Date:  2021-03-16       Impact factor: 39.397

View more
  3 in total

1.  Deciphering the Immune Complexity in Esophageal Adenocarcinoma and Pre-Cancerous Lesions With Sequential Multiplex Immunohistochemistry and Sparse Subspace Clustering Approach.

Authors:  Srinand Sundaram; Eun Na Kim; Georgina M Jones; Shamilene Sivagnanam; Monika Tripathi; Ahmad Miremadi; Massimiliano Di Pietro; Lisa M Coussens; Rebecca C Fitzgerald; Young Hwan Chang; Lizhe Zhuang
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

Review 2.  The Role of Pathology-Based Methods in Qualitative and Quantitative Approaches to Cancer Immunotherapy.

Authors:  Olga Kuczkiewicz-Siemion; Kamil Sokół; Beata Puton; Aneta Borkowska; Anna Szumera-Ciećkiewicz
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

3.  Contribution of MMP14-expressing cancer-associated fibroblasts in the tumor immune microenvironment to progression of colorectal cancer.

Authors:  Yusuke Makutani; Hisato Kawakami; Takahiro Tsujikawa; Kanako Yoshimura; Yasutaka Chiba; Akihiko Ito; Junichiro Kawamura; Koji Haratani; Kazuhiko Nakagawa
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.